Mission, values and decisions
Dawid sets the long-term objective, ethical boundaries, questions and publication decisions. Human judgement remains responsible for what the project claims.
Project 150 / Mission
Project 150 is an independent human–AI research initiative exploring longevity, aging biology, systems medicine and future intervention principles. It is not a pharmaceutical company or a clinical laboratory.
Moonshot objective
150 is not a prediction, guarantee or claim about what medicine can currently achieve. It is a symbolic horizon.
The number forces Project 150 to ask questions that do not fit a five-year optimisation cycle: how to protect function now, how to design research systems that survive changing technology, how to preserve cancer defence while improving repair, and how a person might remain capable of reaching future advances in good condition.
A moonshot objective is useful only when it increases discipline. It must not be used to turn uncertainty into a promise.
Human × AI research
Dawid sets the long-term objective, ethical boundaries, questions and publication decisions. Human judgement remains responsible for what the project claims.
AI supports literature mapping, cross-disciplinary hypothesis generation, causal modelling, adversarial critique, versioning and scientific editing.
Neither human conviction nor AI coherence substitutes for laboratories, preregistration, independent replication, clinical evidence or regulatory oversight.
Research method
State the problem and the evidence hierarchy before searching for an answer.
Separate direct findings from synthesis, speculation and new hypotheses.
Use control theory, reliability, evolution and network science to generate tests—not proof by analogy.
Search prior art, downgrade overlapping claims and remove renamed existing ideas.
Specify matched controls, competing models, hard outcomes and falsification thresholds.
Invite oncology, statistics, immunology, systems biology and trial-design objections.
Keep limitations, null routes, sources and the next decision visible.
Operating principles
Clocks and omics can explain a mechanism. They cannot by themselves prove rejuvenation or longer life.
Test whether the variable exists before designing an intervention around it.
Regeneration and tumour suppression are co-objectives, not efficacy followed by a late safety check.
If the system is not observable, the controller does not escalate.
A superseded idea stays visible so the path from v1.0 to v2.0 can be audited.
A research architecture must never be presented as a personal treatment protocol.
Research trajectory
Adaptive Longevity Therapy: state gating and durable reserve.
Breakthrough Process: error covariance and reference independence.
Show that geometry can be changed independently of burden.
Two fault classes, both sexes, multiple sites and hard function.
Discuss only after causal replication and a credible long-latency safety case.
Founder
Project 150 is a personal, long-term longevity and human–AI research mission founded by Dawid. The public identity is intentionally focused on the work rather than private personal data.
About the founder